dipyridamole has been researched along with Lung Diseases, Obstructive in 17 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on the hypothesis that blood platelets contribute to the pathogenesis of hypoxemic pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD), the effect of a prolonged treatment with dipyridamole, a platelet-inhibiting drug, on hypoxemic pulmonary hypertension was evaluated in a double-blind cross-over study." | 9.06 | Effects of dipyridamole on the hypoxemic pulmonary hypertension of patients with chronic obstructive pulmonary disease. ( Berrettini, M; Costantini, V; Nenci, GG; Parise, P; Todisco, T, 1988) |
| "We describe the occurrence of sudden severe bronchospasm and respiratory arrest following dipyridamole infusion in a patient with chronic obstructive pulmonary disease predominantly of the emphysematous type." | 7.67 | Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging. ( Cerino, M; Laverdiere, M; Lette, J; Prenovault, J; Tremblay, J, 1989) |
| "Based on the hypothesis that blood platelets contribute to the pathogenesis of hypoxemic pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD), the effect of a prolonged treatment with dipyridamole, a platelet-inhibiting drug, on hypoxemic pulmonary hypertension was evaluated in a double-blind cross-over study." | 5.06 | Effects of dipyridamole on the hypoxemic pulmonary hypertension of patients with chronic obstructive pulmonary disease. ( Berrettini, M; Costantini, V; Nenci, GG; Parise, P; Todisco, T, 1988) |
| "We prospectively screened patients referred for intravenous dipyridamole thallium testing and retrospectively reviewed a comparison group of patients who had undergone intravenous dipyridamole testing before our bronchospasm protocol." | 3.70 | Patients with stable chronic obstructive pulmonary disease can safely undergo intravenous dipyridamole thallium-201 imaging. ( Chaney, C; Nishiyama, H; Rauf, GC; Render, ML; Shaffer, J; Simbartl, L; Snow, E; Wexler, LF, 1998) |
| "We describe the occurrence of sudden severe bronchospasm and respiratory arrest following dipyridamole infusion in a patient with chronic obstructive pulmonary disease predominantly of the emphysematous type." | 3.67 | Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging. ( Cerino, M; Laverdiere, M; Lette, J; Prenovault, J; Tremblay, J, 1989) |
| " The test was found to be safe for patients over 70 yr old." | 1.28 | Safety of dipyridamole-thallium imaging in high risk patients with known or suspected coronary artery disease. ( Perper, EJ; Segall, GM, 1991) |
| "Hypertension was equally common in the two groups, but tended to be less well controlled in the epistaxis patients compared to the controls." | 1.28 | Drug-induced epistaxis? ( Shenoi, PM; Watson, MG, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (58.82) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nenci, GG | 4 |
| Berrettini, M | 3 |
| Todisco, T | 3 |
| Parise, P | 2 |
| Costantini, V | 2 |
| Grasselli, S | 1 |
| Mantero, O | 2 |
| Colli, S | 2 |
| Maderna, P | 2 |
| Lo Cicero, S | 1 |
| Bertoli, L | 2 |
| Tremoli, E | 2 |
| Merlini, R | 1 |
| Sirtori, CR | 1 |
| Mirka, T | 1 |
| Ottervanger, JP | 1 |
| Haan, D | 1 |
| Gans, SJ | 1 |
| Hoorntje, JC | 1 |
| Stricker, BH | 1 |
| Leitha, T | 1 |
| Gwechenberger, M | 1 |
| Falger-Banyai, S | 1 |
| Shaffer, J | 1 |
| Simbartl, L | 1 |
| Render, ML | 1 |
| Snow, E | 1 |
| Chaney, C | 1 |
| Nishiyama, H | 1 |
| Rauf, GC | 1 |
| Wexler, LF | 1 |
| Thurnheer, R | 1 |
| Laube, I | 1 |
| Kaufmann, PA | 1 |
| Stumpe, KD | 1 |
| Stammberger, U | 1 |
| Bloch, KE | 1 |
| Weder, W | 1 |
| Russi, EW | 1 |
| Vigdahl, RL | 1 |
| Ferber, RH | 1 |
| Parrish, SL | 1 |
| Perper, EJ | 1 |
| Segall, GM | 1 |
| Watson, MG | 1 |
| Shenoi, PM | 1 |
| Lette, J | 1 |
| Cerino, M | 1 |
| Laverdiere, M | 1 |
| Tremblay, J | 1 |
| Prenovault, J | 1 |
| Gensini, GF | 1 |
| Rostagno, C | 1 |
| Pezza, A | 1 |
| Fanara, F | 1 |
| Castellani, S | 1 |
| Prisco, D | 1 |
| Rogasi, PG | 1 |
| Boddi, M | 1 |
| Neri Serneri, GG | 1 |
| Glbov, A | 1 |
| Kis'ova, K | 1 |
| Mastikova, M | 1 |
| Metodiev, K | 1 |
2 trials available for dipyridamole and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Enhanced plasma beta-thromboglobulin in hypoxemia: effect of dipyridamole.
Topics: Aged; Beta-Globulins; beta-Thromboglobulin; Clinical Trials as Topic; Dipyridamole; Female; Humans; | 1981 |
Effects of dipyridamole on the hypoxemic pulmonary hypertension of patients with chronic obstructive pulmonary disease.
Topics: Aged; Blood Pressure; Dipyridamole; Humans; Hypertension, Pulmonary; Hypoxia; Lung Diseases, Obstruc | 1988 |
15 other studies available for dipyridamole and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Exhausted platelets in chronic obstructive pulmonary disease.
Topics: Aged; beta-Thromboglobulin; Blood Platelets; Dipyridamole; Female; Humans; Lung Diseases, Obstructiv | 1983 |
Platelets, hypoxemia and pulmonary hypertension.
Topics: Blood Platelets; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Hypertension, Pulmon | 1984 |
Pharmacological control of platelet-vessel wall interactions in patients with chronic obstructive airway disease.
Topics: Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Hematopoiesis; Humans; Lung Diseases, Obstruc | 1984 |
Dipyridamole treatment in chronic obstructive airways disease: effect on platelet regeneration time.
Topics: Adult; Blood Gas Analysis; Blood Platelets; Dipyridamole; Humans; Lung Diseases, Obstructive; Male; | 1982 |
Some deleterious effects of intravenous dipyridamole in the presence of chronic lung disease.
Topics: Bronchial Spasm; Coronary Disease; Dipyridamole; Humans; Lung Diseases, Obstructive | 1993 |
[Bronchospasm, apnea and heart arrest following dipyridamole perfusion scintigraphy].
Topics: Aged; Apnea; Bronchial Spasm; Dipyridamole; Heart Arrest; Humans; Lung Diseases, Obstructive; Male | 1993 |
Does dyspnoea during dipyridamole cardiac stress testing indicate bronchospasm and is the pretest clinical history predictive of this side-effect?
Topics: Adult; Aged; Aged, 80 and over; Bronchial Spasm; Dipyridamole; Dyspnea; Exercise Test; Female; Human | 1995 |
Patients with stable chronic obstructive pulmonary disease can safely undergo intravenous dipyridamole thallium-201 imaging.
Topics: Aged; Bronchial Spasm; Bronchodilator Agents; Dipyridamole; Exercise Test; Humans; Image Processing, | 1998 |
Practicability and safety of dipyridamole cardiac imaging in patients with severe chronic obstructive pulmonary disease.
Topics: Ammonia; Bronchoconstriction; Coronary Disease; Dipyridamole; Dyspnea; Female; Heart; Humans; Lung D | 1999 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Di | 1979 |
Safety of dipyridamole-thallium imaging in high risk patients with known or suspected coronary artery disease.
Topics: Age Factors; Cardiac Catheterization; Chest Pain; Contraindications; Coronary Disease; Dipyridamole; | 1991 |
Drug-induced epistaxis?
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Coronary Disease; Dipyr | 1990 |
Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging.
Topics: Aged; Albuterol; Bronchial Spasm; Dipyridamole; Humans; Lung Diseases, Obstructive; Lung Volume Meas | 1989 |
Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension.
Topics: beta-Thromboglobulin; Dipyridamole; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstruct | 1985 |
[Disorders of immunologic profile and interferon response in lung diseases].
Topics: Adjuvants, Immunologic; Adult; Dipyridamole; Humans; Interferon Inducers; Interferon Type I; Lung Di | 1987 |